{
    "page": {
        "original_image_path": "/mnt/sh_flex_storage/home/zehanyu/repos/GPT-Paper/pdfs/cancer_review/JOH 2017 Histological Subtypes of Hepatocellular Carcinoma Are Related To Gene Mutations and Molecular Tumour Classification/pages/page_15.png",
        "current_image_path": "/mnt/sh_flex_storage/home/zehanyu/repos/GPT-Paper/pdfs/cancer_review/JOH 2017 Histological Subtypes of Hepatocellular Carcinoma Are Related To Gene Mutations and Molecular Tumour Classification/pages_ordered/page_15.png",
        "image_width": 2550,
        "image_height": 3300,
        "regions_num": 2,
        "page_idx": 15
    },
    "regions": [
        {
            "idx": 1,
            "thing": "title",
            "score": 62.26,
            "box": [
                386.9,
                301.8,
                632.4,
                364.2
            ],
            "crop_image_path": "/mnt/sh_flex_storage/home/zehanyu/repos/GPT-Paper/pdfs/cancer_review/JOH 2017 Histological Subtypes of Hepatocellular Carcinoma Are Related To Gene Mutations and Molecular Tumour Classification/crops_ordered/page_15/region_1_title.png",
            "text": "References\n"
        },
        {
            "idx": 2,
            "thing": "list",
            "score": 78.25,
            "box": [
                372.4,
                476.7,
                2181.3,
                2898.7
            ],
            "crop_image_path": "/mnt/sh_flex_storage/home/zehanyu/repos/GPT-Paper/pdfs/cancer_review/JOH 2017 Histological Subtypes of Hepatocellular Carcinoma Are Related To Gene Mutations and Molecular Tumour Classification/crops_ordered/page_15/region_2_list.png",
            "text": "1] Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional\nmortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the\nGlobal Burden of Disease Study 2010. Lancet 2012;380:2095-2128.\n\n[2] El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular\ncarcinogenesis. Gastroenterology 2007;132:2557-2576.\n\n[3] Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012;379:1245-1255.\n\n[4] Aaltonen LA, Hamilton SR, World Health Organization., International Agency for Research on\nCancer. Pathology and genetics of tumours of the digestive system. Lyon Oxford: IARC Press ;Oxford\nUniversity Press (distributor); 2000.\n\n[5] Bosman FT, World Health Organization., International Agency for Research on Cancer. WHO\nclassification of tumours of the digestive system, 4th ed. Lyon: International Agency for Research on\nCancer; 2010.\n\n[6] MacSween RNM, Burt AD, Portmann B, Ferrell LD. MacSween's pathology of the liver. 6th ed.\nEdinburgh: Churchill Livingstone,; 2011. p. 1 online resource (1 v.).\n\n[7] Salomao M, Yu WM, Brown RS, Jr., Emond JC, Lefkowitch JH. Steatohepatitic hepatocellular\ncarcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with\nassociated NAFLD/NASH. The American journal of surgical pathology 2010;34:1630-1636.\n\n[8] Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, et al. A novel prognostic subtype\nof human hepatocellular carcinoma derived from hepatic progenitor cells. Nature medicine\n2006;12:410-416.\n\n[9] Durnez A, Verslype C, Nevens F, FeveryJ, Aerts.R, Pirenne J, et al. The clinicopathological and\nprognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible\nprogenitor cell origin. Histopathology 2006;49:138-151.\n\n[10] Zucman-Rossi J, Villanueva Ay Nault JC, Llovet JM. Genetic Landscape and Biomarkers of\nHepatocellular Carcinoma. Gastroenterology 2015;149:1226-1239 e1224.\n\n(11] Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebouissou S, Jeannot E, et al.\nTranscriptome classification of HCC.is related to gene alterations and to new therapeutic targets.\nHepatology 2007;45:42-52.\n\n[12] Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, Chiang DY, et al. Integrative\ntranscriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.\nCancer research 2009;69:7385-7392.\n\n[13] Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, et al. Focal gains of VEGFA\nand molecular classification of hepatocellular carcinoma. Cancer research 2008;68:6779-6788.\n\n[14] Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, et al. Classification and prediction of\nsurvival in hepatocellular carcinoma by gene expression profiling. Hepatology 2004;40:667-676.\n\n[15] Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, et al. Integrated analysis\nof. somatic mutations and focal copy-number changes identifies key genes and pathways in\nhepatocellular carcinoma. Nature genetics 2012;44:694-698.\n\n[16] Schulze K, Imbeaud S, Letouze E, Alexandrov LB, Calderaro J, Rebouissou S, et al. Exome\nsequencing of hepatocellular carcinomas identifies new mutational signatures and potential\ntherapeutic targets. Nature genetics 2015;47:505-511.\n\n[17] Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M, et al. Trans-ancestry\nmutational landscape of hepatocellular carcinoma genomes. Nature genetics 2014;46:1267-1273.\n[18] Nault JC, Calderaro J, Di Tommaso L, Balabaud C, Zafrani ES, Bioulac-Sage P, et al. Telomerase\nreverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation\nof premalignant nodules in hepatocellular carcinoma on cirrhosis. Hepatology 2014;60:1983-1992.\n"
        }
    ]
}